| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032911 |
| Receipt No. | R000037461 |
| Official scientific title of the study | A phase I/II clinical study of Carbon Ion Radiotherapy using 1 fraction for Liver Metastasis from Colorectal Cancer |
| Date of disclosure of the study information | 2018/06/07 |
| Last modified on | 2018/06/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A phase I/II clinical study of Carbon Ion Radiotherapy using 1 fraction for Liver Metastasis from Colorectal Cancer | |
| Title of the study (Brief title) | Dose escalation study of Carbon Ion Radiotherapy for CLM | |
| Region |
|
|
| Condition | ||||||
| Condition | Colon cancer liver metastasis | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Malignancy | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | The objective of this study is to identify the optimal dose of single fraction carbon-ion radiotherapy (CIRT) for colorectal cancer liver metastasis. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Acute toxicity and initial tumor response |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | expanded access |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Prescribed heavy-ion beam (carbon-ion beam) dose.
Initial dose 36Gy(RBE). Dose escalated until dose limiting toxicity is met. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | This study included patients who:
1. has colorectal cancer liver metastasis diagnosed by radiological and clinical findings 2. with Eastern Cooperative Oncology Group performance status (ECOG PS) 0 to 2. 3. had primary colorectal lesions and lymph node metastasis removed totally by surgery (R0 resection) at least 4 weeks prior to enrollment and primary lesions to be histologically proven as CRC 4. have not received chemotherapy for at least 4 weeks prior to enrollment. |
|||
| Key exclusion criteria | This study excluded patients who:
1. has evident vascular invasion. 2. had prior treatment to the specific lesion, 3. with lesions close to the intestine (less than 5 mm), 4. with uncontrollable ascites, 5. with severe liver damage, 6. with active coexisting malignancy, 7. with extra-hepatic lesions including local recurrence 8. were pregnant. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Masaru Miyazaki |
| Organization | Chiba University Graduate School of Medicine |
| Division name | General surgery |
| Address | 1-8-1 Inohana Chuo-ku Chiba City |
| TEL | 043-222-7171 |
| masaru@iuhw.ac.jp | |
| Public contact | |
| Name of contact person | Hirokazu Makishima |
| Organization | National Institutes for Quantum and Radiological Sciences and Technology |
| Division name | National Institutes of Radiological Sciences |
| Address | 4-9-1 Anagawa Inage-ku, Chiba City |
| TEL | 043-206-3306 |
| Homepage URL | |
| makishima.hirokazu@qst.go.jp | |
| Sponsor | |
| Institute | National Institutes for Quantum and Radiological Sciences and Technology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037461 |